Gangat N, Bleeker J, Lynch D, Olteanu H, Letendre L, Tefferi A. Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia. haematol [Internet]. 2022Oct.1 [cited 2024Dec.20];107(10):2523-6. Available from: https://haematologica.org/article/view/haematol.2022.281398